Inflammatory bowel diseases Trials in New York, United States
Conditions / Inflammatory bowel diseases / New York, United States
Inflammatory bowel diseases is a medical condition with active clinical research programs worldwide.
22 total trials for this combination
Showing top 10 of 22 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT02791854 | Improving the Quality of Care for Adults With Inflammatory Bowel Disease | ENROLLING_BY_INVITATION | — |
| NCT03143517 | Fecal Calprotectin Collection Protocol | COMPLETED | — |
| NCT07012395 | A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative Colitis | RECRUITING | — |
| NCT04844606 | A Master Protocol (AMAZ): A Study of Mirikizumab (LY3074828) in Pediatric Participants With Ulcerative Colitis or Crohn's Disease (SHINE-ON) | RECRUITING | — |
| NCT03251118 | A 5-year Longitudinal Observational Study of Patients Undergoing Therapy for Inflammatory Bowel Disease | ACTIVE_NOT_RECRUITING | — |
| NCT00606346 | A Multicenter, Prospective, Long-term, Observational Registry of Pediatric Patients With Inflammatory Bowel Disease | ACTIVE_NOT_RECRUITING | — |
| NCT02566889 | An Efficacy and Safety Study of Infliximab Dose Escalation in Pediatric Participants With Inflammatory Bowel Disease | TERMINATED | PHASE4 |
| NCT02407236 | A Study to Evaluate the Safety and Efficacy of Ustekinumab Induction and Maintenance Therapy in Participants With Moderately to Severely Active Ulcerative Colitis | COMPLETED | PHASE3 |
| NCT06560021 | Utility of Random Biopsies in Patients With Inflammatory Bowel Disease | ENROLLING_BY_INVITATION | NA |
| NCT04835506 | Proactive Infliximab Optimization Using a Pharmacokinetic Dashboard Versus Standard of Care in Patients With Inflammatory Bowel Disease: The OPTIMIZE Trial | ACTIVE_NOT_RECRUITING | PHASE4 |